COMPANY REGISTRATION NUMBER:
16601931
|
Filleted Unaudited Financial Statements |
|
|
Statement of Financial Position |
|
31 March 2026
Fixed assets
Current assets
|
Creditors: amounts falling due within one year |
6 |
428,025 |
|
|
--------- |
|
|
Net current liabilities |
|
427,925 |
|
|
--------- |
|
Total assets less current liabilities |
|
44,815 |
|
|
|
|
|
Creditors: amounts falling due after more than one year |
7 |
|
46,875 |
|
|
-------- |
|
Net liabilities |
|
(
2,060) |
|
|
-------- |
|
|
|
|
Capital and reserves
|
Called up share capital |
|
100 |
|
Profit and loss account |
|
(
2,160) |
|
|
------- |
|
Shareholders deficit |
|
(
2,060) |
|
|
------- |
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
|
Statement of Financial Position (continued) |
|
31 March 2026
These financial statements were approved by the
board of directors
and authorised for issue on
29 June 2026
, and are signed on behalf of the board by:
Company registration number:
16601931
|
Notes to the Financial Statements |
|
Period ended 31 March 2026
1.
General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Lyndhurst, 1 Cranmer Street, Long Eaton, Nottingham, NG10 1NJ.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4.
Investments
|
Shares in group undertakings |
|
£ |
|
Cost |
|
|
At 1 April 2025 |
– |
|
Additions |
472,740 |
|
--------- |
|
At 31 March 2026 |
472,740 |
|
--------- |
|
Impairment |
|
|
At 1 April 2025 and 31 March 2026 |
– |
|
--------- |
|
|
|
Carrying amount |
|
|
At 31 March 2026 |
472,740 |
|
--------- |
|
|
5.
Debtors
|
2026 |
|
£ |
|
Other debtors |
100 |
|
---- |
|
|
6.
Creditors:
amounts falling due within one year
|
2026 |
|
£ |
|
Trade creditors |
2,600 |
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
281,250 |
|
Other creditors |
144,175 |
|
--------- |
|
428,025 |
|
--------- |
|
|
7.
Creditors:
amounts falling due after more than one year
|
2026 |
|
£ |
|
Other creditors |
46,875 |
|
-------- |
|
|
8.
Directors' advances, credits and guarantees
An amount of £95,860 is owed to directors at the period end. The loan is interest free and repayable on demand.